Takeda to collaborate with BC Cancer Agency for new drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2012
Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...Read more
Teva to acquire migraine drug firm at $825 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...Read more
Japan to help export regenerative medicine tech to Qatar, KSA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...Read more
Bayer receives approval for Gadovist injection in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Mar, 2015
Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...Read more
New analysis of EndoBarrier reveals high efficacy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2013
Singapore: Australia-based GI Dynamics has conducted a new meta-analysis that demonstrates EndoBarrier Therapy, an endos...Read more
Novartis announces positive results in COPD portfolio trials
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012
Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...Read more
Korea Drug Development Fund collaborates with PAREXEL
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2012
Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...Read more
Non-small cell lung cancer therapeutics APAC market to touch $2.9 bn by 2019'
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 19 Mar, 2014
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...Read more
GSK announces failure of cancer drug trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2014
Singapore: Glaxosmithkline declared that the phase III study of two anti-HER2 agents lapatinib and trastuzumab did not m...Read more
Singapore invests $60mn to set up nanomedicine research institute
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013
Singapore: Focusing on the medical application of nanotechnology, Nanyang Technological University (NTU) in Singapore ...Read more
NIH to invest $100 mn on HIV research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2013
Singapore: The National Institutes of Health (NIH), US, plans to invest an additional $100 million over the next three ...Read more
Clinical trial drugs must adopt highest GMP standards
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Almac said that Asian clinical trials must adopt highest GMP and GDP standards. Speaking to a news report, Mr...Read more
Merck, Samsung to co-develop diabetes drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2014
Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...Read more
Excelra, H M Pharma to expand Drug Repurposing Solutions outreach in Europe
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 May, 2016
Excelra, headquartered in Hyderabad, India, has announced its collaboration with H M Pharma Consultancy (HMPC), a life s...Read more
Boehringer offers fast-track path to launch biopharma
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2012
Singapore: Boehringer Ingelheim Biopharmaceuticals has installed a fast track process transfer to commercial scale. Comp...Read more
FDA approves Merck's drug for pollen-induced allergic rhinitis
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Apr, 2014
Singapore: US Food and Drug Administration (FDA) has approved Merck's RAGWITEK Tablet indicated as immunotherapy for the...Read more
Former Pfizer executive joins Agenix
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2012
Singapore: Australian drug development company Agenix has appointed international biomedical business development expert...Read more
NovAliX, Kyowa Hakko Kirin sign deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Jan, 2013
Singapore: France-based biopharma company NovAliX entered into a fragment-based drug discovery alliance with Kyowa Hakko...Read more